Oestradiol patches: Supply issue

Supply issue Active

Estradot transdermal 75 mcg patches are in short supply.

Alternative supply of 75 mcg patches

We are listing Estradiol TDP Mylan patches (75 mcg per day) on the Pharmaceutical Schedule from 1 March 2021. The pharmacode is 2605317.

Check the listing in the Schedule(external link)

The supplier, Mylan, has advised that stock is now available for supply.

This product is not Medsafe approved. It will need to be supplied in line with s 29 of the Medicines Act. 

Supplying a medicine under section 29

Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – e.g., doctors. 

We know supplying a medicine under section 29 is not ideal. In this case, however, the alternative would be for patients to have no 75 mcg oestradiol patches. 

We apologise for any inconvenience this causes. 

Read more about supplying medicines under section 29 – Medsafe website(external link)

Information for your patients about what section 29 means – Health Navigator website(external link)

Who to contact

If you are a prescriber or pharmacist with questions about this supply issue:

If you use the oestradiol patches, contact your health professional. PHARMAC cannot give clinical advice about the best treatments for you.